This bill reshapes the regulatory boundary between pesticidal 'plant regulators' and products marketed to support plant physiology by inserting a statutory definition for 'plant biostimulant' into the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and adjusting related terminology. It also creates parallel statutory terms for 'nutritional chemical' and 'vitamin hormone product' to better categorize soil- and plant-input products.
Beyond definitional changes, the measure directs federal agencies to act: it requires the Environmental Protection Agency to update relevant regulations and tasks the Department of Agriculture with a study to identify which biostimulants and practices best deliver soil-health and climate-related benefits. The practical result will be greater legal clarity for manufacturers, supply-chain actors, growers, and regulators about which products need pesticide registration and which are treated as soil/plant amendments or biostimulants.
At a Glance
What It Does
Creates a statutory definition of 'plant biostimulant' and inserts two related terms into FIFRA to narrow the scope of 'plant regulator.' It also directs the EPA to revise implementing regulations and requires USDA to study biostimulant practices that promote soil health.
Who It Affects
Manufacturers and marketers of agricultural inputs (especially biologicals and products marketed to improve nutrient uptake or stress tolerance), EPA and state pesticide enforcement partners, the USDA research apparatus, and growers considering use of biostimulant products.
Why It Matters
The bill reduces regulatory uncertainty around whether a product must be registered and labeled as a pesticide under FIFRA versus marketed as a biostimulant or nutrient aid, and it creates an evidence base to guide adoption of practices that aim to improve soil organic matter, nutrient management, and climate resilience.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The core legal change is an insertion of a clear, functional definition of 'plant biostimulant' into FIFRA. Under the new language a biostimulant may be a substance, a microorganism, or a mixture applied to seeds, plants, the rhizosphere, soil, or other growth media; it must support a plant’s natural processes independently of the nutrient content it supplies and must produce one or more downstream benefits — for example, improved nutrient availability or uptake, better tolerance to abiotic stress, or improved growth or yield.
That independence-from-nutrient-content clause is the statute’s attempt to draw a bright line between inputs intended to supply nutrition and those intended to trigger or support physiological processes.
The bill also rewrites the statutory definition of 'plant regulator' so that certain items are excluded from that pesticide category. Notably, it removes plant biostimulants from the regulatory reach of the 'plant regulator' definition when the biostimulant is of biological origin or when a synthetic compound is structurally and functionally identical to a biologically derived substance.
Two companion terms are added: a 'nutritional chemical,' defined by interaction with plant nutrients and explicitly said to include some biostimulants, and a 'vitamin hormone product,' which covers mixtures of hormones, nutrients, inoculants, or soil amendments. Those additions create intentional overlap and require future interpretive work to sort borderline cases.Operationally, the Act requires the Environmental Protection Agency to revise the implementing regulations in 40 C.F.R. subchapter E to reflect the statutory changes, and it obliges USDA to conduct a focused study assessing which biostimulant types and application practices best improve soil organic matter, reduce volatilization and runoff, restore soil bioactivity, aid carbon sequestration, and enable performance-based outcome standards.
The USDA report must be made public and sent to the Congressional agriculture committees once the study is complete; the statute ties the delivery schedule of the report to the availability of study funds rather than a fixed calendar date.Taken together, the legislative package moves the federal posture from ad hoc, agency-driven classification toward a statute-driven taxonomy of inputs. That change promises faster, more predictable decisions for product developers and for growers evaluating new inputs, but it also creates a new interpretive burden for regulators who must decide how to apply the statutory criteria to real-world formulations and claims.
The Five Things You Need to Know
The bill defines 'plant biostimulant' as a substance, microorganism, or mixture applied to seeds/plants/rhizosphere/soil that supports plant natural processes independently of the nutrient content and thereby improves nutrient availability or use, abiotic stress tolerance, or growth/quality/yield.
It amends the statutory 'plant regulator' definition so that it does not include plant biostimulants that are of biological origin or synthetically derived compounds that are structurally similar and functionally identical to biologically derived substances.
The Act directs the EPA to revise regulations under subchapter E of 40 C.F.R. to implement these changes and gives the Agency 120 days from enactment to complete those regulatory revisions.
The USDA must conduct a study to assess biostimulant types and practices that best increase organic matter, reduce volatilization/runoff/leaching, restore soil bioactivity, improve nutrient management, aid carbon sequestration, and support performance-based outcome standards, and must publish a report to Congress within two years after funds are first made available for the study.
The bill adds defined terms for 'nutritional chemical' (substances that interact with plant nutrients and which can include some biostimulants) and 'vitamin hormone product' (mixtures of plant hormones, nutrients, inoculants, or soil amendments), explicitly creating category overlap that agencies will need to interpret.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Gives the Act the public name 'Plant Biostimulant Act of 2025.' This is a conventional header but signals the bill’s focus for implementation and interagency coordination.
Rewrites 'plant regulator' and inserts new terms
This portion replaces the existing statutory definition of 'plant regulator' and adds exclusions so that specified products are not treated as plant regulators. It also inserts three new definitional terms—'plant biostimulant,' 'nutritional chemical,' and 'vitamin hormone product'—into 7 U.S.C. 136. Practically, the statutory language sets out functional tests (what the product 'acts' to do and whether it is independent of nutrient content) and origin-based exclusions (biological origin or synthetic functional analogues). That structure forces a switch from claim-based classifications toward a statutory, science-framed standard, which will change how regulators evaluate marketing claims and product formulations.
EPA must update implementing regulations
The bill requires the Environmental Protection Agency to revise regulations under subchapter E of title 40, Code of Federal Regulations, to align the regulatory framework with the new statutory definitions. The statutory text gives EPA a 120-day deadline to make those revisions, creating a compressed window for rule updates, interagency consultation, and stakeholder outreach. Because the CFR changes will affect labeling, registration decisions, and enforcement priorities, EPA will need to develop guidance explaining how to apply the statutory tests to specific product types and claims.
USDA-directed study on effective biostimulant practices
The Secretary of Agriculture must conduct a study that evaluates which biostimulant types and application practices best achieve enumerated soil-health outcomes—raising organic matter, reducing volatilization and runoff, restoring soil bioactivity, aiding carbon sequestration, and enabling performance-based standards. The statute requires the USDA to publish and deliver a report to the agriculture committees of both chambers within two years after funds are first made available for the study, which ties timing to appropriations rather than to enactment. The study’s scope is broad and explicitly seeks to identify performance-based outcomes that could later inform program design or incentive structures.
This bill is one of many.
Codify tracks hundreds of bills on Agriculture across all five countries.
Explore Agriculture in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Manufacturers of biological biostimulants — The statutory exclusion for products of biological origin removes a key regulatory uncertainty that has prompted some firms to pursue costly pesticide registrations; clearer categories lower regulatory risk and transactional costs.
- Growers pursuing sustainable practices — Farmers seeking inputs that improve nutrient efficiency, drought tolerance, or soil health will have clearer product categories to compare, and USDA’s study could produce actionable guidance tied to measurable outcomes.
- Agritech and startup developers — Companies creating microbial or biologically based formulations gain a more predictable pathway to market and may find it easier to attract investment without the specter of unexpected pesticide classification.
- Soil researchers and extension services — The mandated USDA study will produce consolidated evidence and metrics that researchers and extension programs can use to advise growers and to design trials aligned to policy-relevant outcomes.
Who Bears the Cost
- Environmental Protection Agency — EPA must complete regulatory revisions on a 120-day clock, prepare guidance, and handle increased classification inquiries and potential enforcement disputes, all of which require staff time and resources.
- Manufacturers with borderline products — Firms selling inputs that straddle the nutritional chemical/biostimulant/plant regulator line may face re-labeling, reclassification, or compliance costs as agencies interpret the new definitions.
- Small ag-input firms — Smaller vendors may struggle with the administrative burden of adapting labels, claims, and product documentation to newly clarified statutory categories and could face market friction during the transition.
- USDA (budgetary and programmatic) — Conducting the mandated study and translating results into usable guidance depends on appropriated funds; the requirement places planning and execution demands on researchers and program staff without a fixed appropriation in the text.
Key Issues
The Core Tension
The bill balances two legitimate goals—removing unnecessary pesticide regulation to accelerate biologically based innovation and clarifying product categories for market stability, versus the need to ensure scientific rigor, prevent misleading efficacy claims, and protect environmental and public health; achieving both quickly is difficult because clearer categories require scientific definitions and enforcement capacity that the agencies must develop under tight timelines and without built-in funding for the resulting workload.
The Act attempts to create clean legal categories, but the statutory language intentionally creates overlap. The 'plant biostimulant' definition requires that the product act independently of nutrient content — a scientific and regulatory standard that will be difficult to apply in practice.
Many commercial formulations contain both nutritive components and bioactive agents; deciding which ingredient or claimed mechanism is dispositive will require substantive technical review and potentially new data standards. Likewise, the 'nutritional chemical' definition explicitly includes some biostimulants, so companies and regulators will confront cross-category cases where a product could legitimately be called both a nutritional chemical and a biostimulant.
The 120-day deadline for EPA to revise regulations is another practical pressure point. That timeline compresses rulemaking or rule-amendment processes that usually include public notice, comment, and interagency coordination.
Rapid regulatory change could improve predictability quickly, but it also raises the risk of under-specified guidance, inconsistent state-level adoption, or legal challenges. The USDA study lists many desirable outcomes (organic matter, reduced volatilization/leaching, carbon sequestration, performance-based standards), but it ties delivery to the availability of funds rather than to a fixed date and does not prescribe research methods or minimum data standards.
As a result, the study's usefulness will hinge on funding levels, study design choices, and the degree to which USDA consults independent science and stakeholder groups.
Finally, the statute does not set efficacy testing, label-claim substantiation, or post-market surveillance standards specific to biostimulants. That omission leaves a regulatory gap: products may be carved out of pesticide registration but still make efficacy or environmental claims without a new, consistent evidentiary framework.
Policymakers and regulators will need to decide whether to create claim substantiation requirements outside FIFRA or to rely on existing consumer-protection and labeling authorities, which may be less well-suited to agronomic performance claims.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.